Information Journal Paper
APA:
CopyWU, S.G.. (2015). USING THE LYMPH NODE RATIO TO EVALUATE THE PROGNOSIS OF STAGE II/III BREAST CANCER PATIENTS WHO RECEIVED NEOADJUVANT CHEMOTHERAPY AND MASTECTOMY. CANCER RESEARCH AND TREATMENT, 47(4), 757-764. SID. https://sid.ir/paper/713921/en
Vancouver:
CopyWU S.G.. USING THE LYMPH NODE RATIO TO EVALUATE THE PROGNOSIS OF STAGE II/III BREAST CANCER PATIENTS WHO RECEIVED NEOADJUVANT CHEMOTHERAPY AND MASTECTOMY. CANCER RESEARCH AND TREATMENT[Internet]. 2015;47(4):757-764. Available from: https://sid.ir/paper/713921/en
IEEE:
CopyS.G. WU, “USING THE LYMPH NODE RATIO TO EVALUATE THE PROGNOSIS OF STAGE II/III BREAST CANCER PATIENTS WHO RECEIVED NEOADJUVANT CHEMOTHERAPY AND MASTECTOMY,” CANCER RESEARCH AND TREATMENT, vol. 47, no. 4, pp. 757–764, 2015, [Online]. Available: https://sid.ir/paper/713921/en